Scripps study to focus on text messaging to improve diabetes
SAN DIEGO – Scripps Whittier Diabetes Institute will use a $2.9 million grant from the National Institutes of Health to study the effects of using text messaging to improve Type 2 diabetes among high-risk Hispanic patients in San Diego County.
“We believe our work will identify innovative, cost-effective ways to improve diabetes care and help to reduce health disparities among this underserved population,” said Dr. Athena Philis-Tsimikas, corporate vice president for the Scripss Whittier Diabetes Institute, in a press release.
Up to 55% of U.S. Hispanics born in 2000 are expected to develop diabetes during their lifetime, according to the National Alliance for Hispanic Health.
The study, called Dulce Digital-Me, will recruit 414 participants from among Hispanic adults of low socioeconomic status with poorly controlled Type 2 diabetes. The patients will use wireless devices to track their blood sugar levels and medication adherence over a six-month period.
Half of the participants in the study will receive personalized text messages encouraging proper nutritional habits, emphasizing the benefits of physical activities, and reminding them to monitor blood sugar and take medications on a regular basis. They will also be asked to respond periodically to brief questions about their diet, exercise and stress levels via text message. The algorithm-driven text messages will be individualized based on the monitoring data and responses collected from each participant.
The other half of participants will receive standard messages modeled off the Institute’s original Dulce program, which demonstrated the effectiveness of using text messaging to improve blood sugar control in a high-risk Hispanic population with Type 2 diabetes two years ago.
In this new study, researchers will measure hemoglobin A1c levels, LDL cholesterol levels and systolic blood pressure to see if participants who received the personalized messages have better results than those who received standard messages. They will also look for differences in patient-doctor/nurse communication, medication adherence and cost effectiveness between the two groups.
Validic, Sutter Health lead pilot on patient-generated health data
DURHAM, N.C. – Validic, a digital health platform provider, and Sutter Health are partnering on a federal pilot project to determine how patient-generated health data can best be delivered to care teams and researchers to improve the care and outcomes of patients.
Validic and Sutter Health, a Sacramento, Calif-based nonprofit network of hospitals and doctors, were selected by Accenture Federal Services, to guide one of two pilot projects. Results from the pilot will help Accenture, which is under contract with the Office of the National Coordinator for Health IT, develop a research paper that identifies barriers to wider use of patient-generated data in clinical care and recommend how those barriers can be removed.
The pilot kicked off last month with patients with Type 2 diabetes. Patients received Sutter Health’s Mpower (Motivating Patients Online with Enhanced Resources) app on their smartphone. Using Validic’s digital health platform, the Mpower app has the ability to securely connect to various devices that measure blood glucose, blood pressure, level of activity and weight. The system interprets the information and provides visual feedback and motivational incentives to keep patients on track with their care program, and alert care teams when attention is required.
The Mpower app also leverages Validic’s VitalSnap, which enables patients to capture and share information from analog in-home medical devices using their smartphone cameras.
The pilot is part of the “Conceptualizing a Data Infrastructure for the Capture, Use and Sharing of Patient-Generated Health Data in Care Delivery and Research through 2024” project funded by ONC, a division of the Department of Health and Human Services. The goal of this and other pilots: implement and use the most advanced health information technology and the electronic exchange of health information to improve patient care.
Health2Sync, Taiwan Health Ministry expand diabetes care
TAIPEI, Taiwan – Health2Sync, an online diabetes management company, has partnered with the Taiwan Ministry of Health and Welfare to bring care nationwide. “We want to leverage digital technology and data analytics to provide patients and care providers a mobile app and web management platform that can raise the effectiveness of diabetes management,” said Hsiu-Mei Chen, section chief of the MOHW’s department of nursing and healthcare, in a press release. Since September, Health2Sync and MOHW have enabled more than 30 hospitals and clinics to provide real-time tracking and immediate feedback to patients. “Through this, we want to motivate patients to self-manage, merge online and offline resources, and enable comprehensive care for diabetes,” said Chen. Health2Sync is building similar management programs with partners in Japan, Hong Kong and Thailand.
Common Sensing kicks off insulin cap study
CAMBRIDGE, Mass. – Common Sensing, partnering with Sanofi and Dexom at the Joslin Diabetes Center in Boston, has kicked off a study of its Gocap insulin pen cap. The Gocap is a Bluetooth-enabled insulin-monitoring device that fits on existing disposable injectors and automatically generates an insulin logbook that can be wirelessly shared with care providers and family. Users can see and share their data over the cloud, and receive reminders and alerts from the accompanying Gocap mobile app. The study will look at the use of disposable insulin pens with the smart cap and associated glycemic control. Both insulin pen use and continuous blood glucose response will be measured automatically around the clock for 125 participants.
biotricity device component receives FDA clearance
REDWOOD CITY, Calif. – biotricity has received clearance from the U.S Food and Drug Administration for a key component of its bioflux monitoring device. “Receiving a 510(k) clearance is a significant accomplishment toward our goal of enabling physicians to remotely monitor and diagnose patients with cardiovascular disease and coronary heart disease,” said Waqaas Al-Siddiq, founder and CEO of biotricity. The company develops multiple solutions for a variety of chronic illnesses by designing monitoring devices paired with chronic care management tools. Once cleared for the market, the device will be used by physicians and hospitals in the diagnostic process, then by patients for long-term care management.
PointClickCare launches skin and wound app
NASHVILLE, Tenn. – A new skin and wound mobile app that integrates with PointClickCare’s EHR platform tracks and documents healing in senior patients. “The secure, HIPAA-compliant, EHR-linked skin and wound smartphone app from PointClickCare has allowed us to develop consistency in our wound assessment and documentation,” said Amy Cassata, RN, quality improvement nurse consultant at Great Lakes Healthcare Group. “This consistency, with the ability to track and communicate wound status, is a significant part of our risk mitigation strategy.” The mobile app, powered by Swift Medical, automates best practices in documenting wounds, which will help to improve care delivery and reduce risk.
Orbita launches home health solution
BOSTON – Orbita has launched the first HIPAA-compliant, cloud-based solution designed specifically to improve the effectiveness and efficiency of connected home health care. “Wireless connectivity, smartphones and connected devices are the current superstars of digital health, but truly transforming connected home health care requires a focus on capabilities that directly impact patient engagement and provider efficiency,” said Bill Rogers, Orbita founder and CEO. Orbita’s offering includes built-in capabilities to capture and analyze data from wearables, sensor-embedded home health devices and remote care coordination. It translates the data collected and makes it actionable for clinicians, caregivers, patients and family.
Study shows self-monitoring tools make a difference, ResMed says
LOS ANGELES – More than 87% of CPAP users were compliant with their therapy when they used ResMed’s myAir and were monitored with AirView, according to the results of a study that will be presented at the CHEST annual meeting on Oct. 26. That’s compared to 70% of PAP users who were compliant when they were only monitored with AirView. “This new study shows that online self-monitoring tools engage patients and significantly improve their compliance and adherence to treatment,” said Adam Benjafield, ResMed’s medical director. The results of the observational study were based on 128,000 people with sleep apnea. myAir, which is available on the web and via iPhone app to patients using ResMed’s Air10 devices, allows users to track the progress of their therapy between visits to their clinicians, including their daily sleep scores, details on four key treatment metrics and personalized coaching tips. Without wireless monitoring, CPAP adherence can be as low as 50%, according to ResMed.